Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion

S Jhunjhunwala, C Hammer, L Delamarre�- Nature Reviews Cancer, 2021 - nature.com
Immune checkpoint blockade, which blocks inhibitory signals of T cell activation, has shown
tremendous success in treating cancer, although success still remains limited to a fraction of�…
Save Cite Cited by 756 Related articles

[CITATION][C] Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion

S Jhunjhunwala, C Hammer, L Delamarre�- Nature Reviews Cancer, 2021 - cir.nii.ac.jp
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ�…
Cite

Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion

S Jhunjhunwala, C Hammer…�- Nature reviews�…, 2021 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint blockade, which blocks inhibitory signals of T cell activation, has shown
tremendous success in treating cancer, although success still remains limited to a fraction of�…
Cite

Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion.

S Jhunjhunwala, C Hammer, L Delamarre�- Nature reviews. Cancer, 2021 - europepmc.org
Immune checkpoint blockade, which blocks inhibitory signals of T cell activation, has shown
tremendous success in treating cancer, although success still remains limited to a fraction of�…
Cite